Home > Products > Biosimilars

BioSIM anti-Human IL-1b Antibody (Gevokizumab Biosimilar), Research Grade

Catalog: SIM0363
Cost advantage to: SIM0049
Product Details Specifications Application References Related Products

Product Details

This biosimilar antibody shares variable regions with therapeutic antibody Gevokizumab, ideal for research. Gevokizumab, a fully humanized monoclonal antibody, binds human IL-1β (a monocyte-derived pro-inflammatory cytokine). It targets a unique IL-1β epitope, reducing IL-1-receptor binding to neutralize IL-1β, used in preclinical research (in vitro/in vivo) for type 1 diabetes, inflammation, RA, cardiovascular biology, and cancer immunotherapy.
 

Specifications

Product Name BioSIM anti-Human IL-1b Antibody (Gevokizumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype /
Target IL-1b
Other Names XOMA052, CAS: 1129435-60-4
CAS 1129435-60-4
Reactivity Human
Host Species Humanized
Background This biosimilar antibody shares variable regions with therapeutic antibody Gevokizumab, ideal for research. Gevokizumab, a fully humanized monoclonal antibody, binds human IL-1β (a monocyte-derived pro-inflammatory cytokine). It targets a unique IL-1β epitope, reducing IL-1-receptor binding to neutralize IL-1β, used in preclinical research (in vitro/in vivo) for type 1 diabetes, inflammation, RA, cardiovascular biology, and cancer immunotherapy.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products